Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q4 2017 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$1.58M$1.58Mderived+10.6% vs Q4 2016 Net Income-$1.32M-$1.32MderivedN/M vs Q4 2016 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$876,111+9.5% Operating Incomederived-$989,063N/M Operating Cash Flowderived-$864,986N/M Free Cash Flowderived-$10,338,061N/M Margins · derivedGross margin55.4%−0.6 pt vs Q4 2016
Operating margin-62.6%−105.1 pt vs Q4 2016
Net margin-83.2%−81.5 pt vs Q4 2016
ended Dec 31, 2017 · filed Apr 2, 2018 · 92 d after period end